Founder, NanoBio Corp.; Professor of Internal Medicine and Biomedical Engineering; Ruth Dow Doan
Professor of Nanotechnology; Chief, Allergy Division, Medical School; Director,
Michigan Nanotechnology Institute for Medicine and Biological Sciences
Technology: Nanostat™, a nano emulsion made of soybean oil, alcohol, water, and surfactants emulsified into droplets 200 to 600 nanometers in diameter. They have proven effective at killing a variety of bacteria, fungi, and viruses in laboratory tests.
Company: NanoBio Corp. The company, founded in 2000, is a spin-out of the Michigan Nanotechnology Institute for Medicine and Biological Sciences at the University of Michigan. Baker heads the institute and the company.
Products: Potential target treatments for cold sores, nail fungus, acne, and cystic fibrosis; and mucosal vaccines against influenza, hepatitis B, and RSV.
History: Over $100 million invested in the NanoStat™ technology platform through research grants and equity investments.
Exclusive licensing agreement with GlaxoSmithKline, plc (GSK) for the over-the-counter (OTC) use of NB-001, a novel, patented compound representing the next advance in the treatment of herpes labialis (cold sores).